Labormedizin Medizinisches Infektiologiezentrum Berlin DAKKS Logo

Studien und Publikationen

2025

ESCMID 2025 - P0025 / Evaluation of the new DxI 9000 Anti-HIV Antibody and Antigen Combo assay

ESCMID 2025 - P0056 / HDV full genome sequencing and genotype determination in a Berlin cohort

ESCMID 2025 - P0075 / Evaluation of the new DxI 9000 ACCESS anti-HCV assay

ESCMID 2025 - P0076 / Evaluation of the new DxI 9000 ACCESS HBsAg assay

ESCMID 2025 - P0319 / Ongoing MPXV infections in the Berlin MSM cohort Multiplex PCR for differentiation between MPXV clade I; Ib and clade II

ESCMID 2025 - P0359 / Sequencing of MPXV positive samples in Berlin 2022 to 2025

Nature 650, no. 8102 (2025): 701–709. - Sustained HIV-1 Remission after Heterozygous CCR5Δ32 Stem Cell Transplantation.

Blood 146, Supplement 1 (2025): 2484–2484. - Graft-versus-HIV-Reservoir Reactivity: Long Term HIV Remission after Allogeneic Stem Cell Transplantation from a Donor with Active CCR5.

The Lancet Microbe 6, no. 12 (2025): 10123. - Detection of H5N1 Clade 2.3.4.4b in External Quality Assessment Programmes: A Pandemic Preparedness Initiative.

International Journal of Medical Microbiology 319, no. 6 (2025): 151656. - From Crisis to Routine – Standardization of SARS-CoV-2 Genome Detection by Enhanced EQA Schemes in a Scientific Pandemic Network.

Clinical Infectious Diseases 81, no. 3 (2025): 539–542. - HIV-2 EU—Supporting Standardized HIV-2 Drug Resistance Interpretation: An Update.

Journal of Medical Virology 97, no. 2 (2025): e70169. - Hepatitis C Virus Saint Petersburg Variant Detection With Machine Learning Methods.

2021

GfV 2019 - P60/ Comparison of the new Cepheid HIV VL XC Assay with the established Abbott Alinity m in HIV-1 viral load measurement

ECCMID 2021 - 03132/ Performance of Abbott Alinity m and RealTime SARS-CoV-2 assays in clinical practice

ECCMID 2021 - 04241/ Performance comparison of the Hologic Aptima SARS-CoV-2 assay with the Abbott RealTime, the Abbott Alinity m and an inhouse SARS-CoV-2 assay

ECCMID 2021 - 03002/ Comparison of the new Cepheid HIV VL XC Assay with the established Abbott Alinity m in HIV-1 viral load measurement

ESCV 2021 - P176/ Performance of the new Abbott Realtime SARS-CoV-2 assay

ESCV 2021 - P160/ Evaluation of the new Alinity m Resp-4-Plex assay

ESCV 2021 - P048/ Comparison of the Alinity m system with the established Abbott RealTime and Hologic Aptima Quant Assay in HIV-1, HCV and HBV viral load measurement

ESCV 2021 - P076/ No impact on HIV-1 quantification by the Alinity m HIV-1 assay due to mutations in the HIV-1 integrase gene

ESCV 2021 - P159/ Pool testing from throat wash and nasopharyngeal swabs for SARS-CoV-2 RNA with high sensitivity

Experimental and Clinical Endocrinology & Diabetes* 129, no. 11 (2021): 798–802. - Functional Hypogonadism and Testosterone Deficiency in Aging Males With and Without HIV Infection.

Journal of Laboratory Medicine* 45, no. 4–5 (2021): 213–223. - Simultaneous Identification of Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium, and Trichomonas vaginalis – Multicenter Evaluation of the Alinity m STI Assay.

MMW – Fortschritte der Medizin* 163, no. S2 (2021): 28–35. - Vergleich der HIV-Therapie im städtischen und ländlichen Raum.

Journal of Clinical Virology* 136 (März 2021): 104755. - Adapting the Geno2pheno [Coreceptor] Tool to HIV-1 Subtype CRF01_AE by Phenotypic Validation Using Clinical Isolates from South-East Asia.

Frontiers in Medicine* 7 (3. Februar 2021): 616648. - Preventing SARS-CoV-2 In-Hospital Infections in Cardiovascular Patients and Medical Staff: An Observational Study From the German Heart Center Berlin.

Clinical Infectious Diseases* 72, no. 3 (1. Februar 2021): 503–509. - Human Immunodeficiency Virus–2 (HIV-2): A Summary of the Present Standard of Care and Treatment Options for Individuals Living with HIV-2 in Western Europe.

2016

ECCMID 2016 - P0046/ Comparison of the recently launched Hologic Aptima HCV Quant Dx assay with the established Abbott RealTime HCV assay in viral load measurement.

CROI 2016 - 525/ Comparison of Four HCV Viral Load Assays at High Viral Load

ESCV Lissabon 2016 - PP40/ Comparison of the recently launched Hologic Aptima HBV Quant assay with the established Abbott RealTime HBV assay in viral load measurement

eurDrugRes Rom 2016 - O-04/ Next generation sequencing in routine HIV-1 resistance diagnostic - frequency of additional resistance relevant mutations in 2% and 1% population proportions

HIV Glasgow 2016 - P358/ Frequency of additional resistance relevant mutations in 2% and 1% population proportions in next generation sequencing in routine HIV-1 resistance diagnostics

Zeitschrift für Gastroenterologie* 54, no. 12 (2016): 1343–1404. - Detection of a Genetic Footprint of the Sofosbuvir Resistance-Associated Substitution S282T after HCV Treatment Failure.

Journal of Clinical Virology* 82 (2016): S41. - Comparison of the Recently Launched Hologic Aptima HBV Quant Assay with the Established Abbott RealTime HBV Assay in Viral Load Measurement.

Journal of Clinical Virology* 81 (2016): 82–89. - New Findings in HCV Genotype Distribution in Selected West European, Russian and Israeli Regions.

Clinics and Research in Hepatology and Gastroenterology* 40, no. 3 (2016): e23–e25. - Persisting Hepatitis E Virus Infection Leading to Liver Cirrhosis despite Recovery of the Immune System in an HIV-Infected Patient.

PLOS ONE* 11, no. 5 (2016): e0155869. - Geno2pheno[HCV] – A Web-Based Interpretation System to Support Hepatitis C Treatment Decisions in the Era of Direct-Acting Antiviral Agents.

2013

Clinical Infectious Diseases* 56, no. 11 (2013): 1654–1658. - HIV-2EU: Supporting Standardized HIV-2 Drug Resistance Interpretation in Europe.

2012

Journal of the International AIDS Society* 15, Suppl. 4 (2012): 18417. - Ménage à Trois: Increased Prevalence of Syphilis Infection in HIV-Positive MSM with Acute Hepatitis C.

Intervirology* 55, no. 2 (2012): 102–107. - HIVGRADE: A Publicly Available, Rules-Based Drug Resistance Interpretation Algorithm Integrating Bioinformatic Knowledge.

Journal of the International AIDS Society* 15, no. 6, Suppl. 4 (2012). - Activation and Inflammation Markers in HIV-1-Infected Patients in Dependency of Treatment Strategies.

Journal of the International AIDS Society* 15, no. 6, Suppl. 4 (2012). - Sexually Transmitted Infection with an Immune-Escape Mutant Hepatitis B Virus (HBV) in an HBV-Vaccinated Individual with Acute HIV-HCV Infection.

Journal of the International AIDS Society* 15, no. 6, Suppl. 4 (2012). - HIV-1 Drug Resistance Testing at Low Viral Load May Help to Differentiate between Ongoing Replication and Release from Reservoirs.

Journal of the International AIDS Society* 15, no. 6, Suppl. 4 (2012). - Genotypic HIV-Coreceptor Tropism Prediction with Geno2pheno [Coreceptor]: Differences Depending on HIV-1-Subtype.

Current Opinion in HIV and AIDS* 7, no. 5 (2012): 470–477. - HIV Population Genotypic Tropism Testing and Its Clinical Significance.

Journal of Clinical Virology* 54, no. 3 (2012): 279–281. - The Detection of HBsAg Mutants Expressed in Vitro Using Two Different Quantitative HBsAg Assays.

Medical Microbiology and Immunology* 201, no. 1 (2012): 7–16. - APOBEC3G/F as One Possible Driving Force for Co-Receptor Switch of the Human Immunodeficiency Virus-1.

2009

Infection Control & Hospital Epidemiology* 30, no. 3 (2009): 299–300. - Late Appearance of Hepatitis C Virus RNA After Needlestick Injury: Necessity for a More Intensive Follow-Up.

mib Dienstleistung GmbH

Email: mib@mvz-mib.de
Telefon: ++49 (030) 344091040
Fax: ++49 (030) 3440910413

Oudenarder Str. 16-20 13347 Berlin (Wedding)

MVZ mib AG

Email: labor@mvz-mib.de
Telefon: ++49 (030) 344091040
Fax: ++49 (030) 3440910412